StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Pulmicort (budesonide) — Europe YoY actual by Quarter

Pulmicort (budesonide) — Europe YoY actual (%) (%)

QuarterlyAnnual

AstraZeneca Pulmicort (budesonide) — Europe YoY actual: -5.0% in Q2 2026, up 9.0 pts from a year earlier.

Latest, Q2 2026
-5.0%
Period ended Jun 30, 2026
Change on a year earlier
+9.0 pts
-14.0% in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Pulmicort | 120 | | 13 | | 9 | | 2 | | 11 | | 97 | | 20 | | 15 | | 14 | | ( 5 ) | | ( 9 ) | | 7 | | ( 17 ) | | ( 17 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPulmicort (budesonide) — Europe YoY actual (%) (%)Year on yearSource
Q2 2026Jun 30, 2026-5.0%+9.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026-11.0%-9.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-18.0%-26.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-15.0%-25.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025-14.0%-20.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025-2.0%-2.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20248.0%+9.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202410.0%+21.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20246.0%+13.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20240.0%-12.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-1.0%+18.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023-11.0%-7.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023-7.0%-3.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202312.0%+1.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-19.0%-50.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-4.0%-9.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Pulmicort (budesonide) — Europe YoY actual (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-pulmicort-eu-act-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.